Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment-Reference-Cited by-同舟云学术

Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment

Published:2021-10 Issue:5 Volume:20 Page:416-425
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Chang Xiu-Juan,Shi Yi-Wen,Wang Jing,Liu Hua-Bao,Chen Yan,Zhu Xiao-Ning,Chen Yong-Ping,Yu Zu-Jiang,Shang Qing-Hua,Tan Lin,Li Qin,Jiang Li,Xiao Guang-Ming,Chen Liang,Lu Wei,Hu Xiao-Yu,Long Qing-Hua,An Lin-Jing,Zou Zi-Yuan,Wong Vincent Wai-Sun,Yang Yong-Ping,Fan Jian-Gao

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference52 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Lancet Gastroenterol Hepatol,2018

2. Hepatic decompensation in cirrhotic patients receiving antiviral therapy for chronic hepatitis B;Lee;Clin Gastroenterol Hepatol,2020

3. Comparison of long-term clinical outcomes between spontaneous and therapy-induced HBsAg seroclearance;Choi;Hepatology,2020

4. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease;Pais;Eur J Intern Med,2015

5. Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors;Wang;Dig Dis Sci,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gubra Amylin‐NASH Diet Induced Nonalcoholic Fatty Liver Disease Associated with Histological Damage, Oxidative Stress, Immune Disorders, Gut Microbiota, and Its Metabolic Dysbiosis in Colon;Molecular Nutrition & Food Research;2024-07-05

2. The Association Between Weight Loss and Hepatitis B Surface Antigen Seroclearence in Chronic Hepatitis B Patients;Hepatitis Monthly;2024-04-29

3. The global burden of fatty liver disease: the major impact of China;Hepatobiliary Surgery and Nutrition;2024-02

4. Predictors of treatment efficacy with nucleos(t)ide analogues for chronic hepatitis B;Experimental and Clinical Gastroenterology;2023-07-26

5. Hypertension and NAFLD risk: Insights from the NHANES 2017–2018 and Mendelian randomization analyses;Chinese Medical Journal;2023-07-14